These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22323663)

  • 1. Phase I study of terameprocol in patients with recurrent high-grade glioma.
    Grossman SA; Ye X; Peereboom D; Rosenfeld MR; Mikkelsen T; Supko JG; Desideri S;
    Neuro Oncol; 2012 Apr; 14(4):511-7. PubMed ID: 22323663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma.
    Nabors LB; Supko JG; Rosenfeld M; Chamberlain M; Phuphanich S; Batchelor T; Desideri S; Ye X; Wright J; Gujar S; Grossman SA;
    Neuro Oncol; 2011 Dec; 13(12):1324-30. PubMed ID: 21954442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochloride.
    Grossman SA; Carson KA; Batchelor TT; Lesser G; Mikkelsen T; Alavi JB; Phuphanich S; Hammour T; Fisher JD; Supko JG
    Clin Cancer Res; 2006 Sep; 12(17):5174-81. PubMed ID: 16951236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
    Grossman SA; Carson KA; Phuphanich S; Batchelor T; Peereboom D; Nabors LB; Lesser G; Hausheer F; Supko JG;
    Neuro Oncol; 2008 Aug; 10(4):608-16. PubMed ID: 18577560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias.
    Tibes R; McDonagh KT; Lekakis L; Bogenberger JM; Kim S; Frazer N; Mohrland S; Bassett D; Garcia R; Schroeder K; Shanmugam V; Carpten J; Hagelstrom RT; Beaudry C; Von Hoff D; Shea TC
    Invest New Drugs; 2015 Apr; 33(2):389-96. PubMed ID: 25523151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.
    Phuphanich S; Supko JG; Carson KA; Grossman SA; Burt Nabors L; Mikkelsen T; Lesser G; Rosenfeld S; Desideri S; Olson JJ
    J Neurooncol; 2010 Oct; 100(1):95-103. PubMed ID: 20213332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
    Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
    Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
    VanderSpek L; Fisher B; Bauman G; Macdonald D
    Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma.
    Prados MD; Lamborn KR; Chang S; Burton E; Butowski N; Malec M; Kapadia A; Rabbitt J; Page MS; Fedoroff A; Xie D; Kelley SK
    Neuro Oncol; 2006 Jan; 8(1):67-78. PubMed ID: 16443950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II clinical safety studies of terameprocol vaginal ointment.
    Khanna N; Dalby R; Tan M; Arnold S; Stern J; Frazer N
    Gynecol Oncol; 2007 Dec; 107(3):554-62. PubMed ID: 17905420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR).
    Ahluwalia MS; Ozair A; Rudek M; Ye X; Holdhoff M; Lieberman FS; Piotrowski AF; Nabors B; Desai A; Lesser G; Huang RC; Glenn S; Khosla AA; Peereboom DM; Wen PY; Grossman SA
    Cell Rep Med; 2024 Jul; 5(7):101630. PubMed ID: 38955178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.
    Odia Y; Kreisl TN; Aregawi D; Innis EK; Fine HA
    J Neurooncol; 2015 Oct; 125(1):191-5. PubMed ID: 26285768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
    Reardon DA; Quinn JA; Rich JN; Desjardins A; Vredenburgh J; Gururangan S; Sathornsumetee S; Badruddoja M; McLendon R; Provenzale J; Herndon JE; Dowell JM; Burkart JL; Newton HB; Friedman AH; Friedman HS
    Cancer; 2005 Oct; 104(7):1478-86. PubMed ID: 16088964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.
    Cloughesy TF; Filka E; Kuhn J; Nelson G; Kabbinavar F; Friedman H; Miller LL; Elfring GL
    Cancer; 2003 May; 97(9 Suppl):2381-6. PubMed ID: 12712460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas.
    Rudek MA; New P; Mikkelsen T; Phuphanich S; Alavi JB; Nabors LB; Piantadosi S; Fisher JD; Grossman SA
    J Neurooncol; 2011 Nov; 105(2):375-81. PubMed ID: 21547395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas.
    Yao H; Liu J; Zhang C; Shao Y; Li X; Feng M; Wang X; Gan W; Zhou Y; Huang Y
    J Clin Neurosci; 2021 Aug; 90():82-88. PubMed ID: 34275586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.
    Galanis E; Buckner JC; Maurer MJ; Reid JM; Kuffel MJ; Ames MM; Scheithauer BW; Hammack JE; Pipoly G; Kuross SA
    Invest New Drugs; 2005 Oct; 23(5):495-503. PubMed ID: 16133802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas.
    Peereboom DM; Supko JG; Carson KA; Batchelor T; Phuphanich S; Lesser G; Mikkelsen T; Fisher J; Desideri S; He X; Grossman SA;
    J Neurooncol; 2010 Nov; 100(2):261-8. PubMed ID: 20449631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs.
    Chang SM; Kuhn J; Wen P; Greenberg H; Schiff D; Conrad C; Fink K; Robins HI; Cloughesy T; De Angelis L; Razier J; Hess K; Dancey J; Prados MD;
    Invest New Drugs; 2004 Nov; 22(4):427-35. PubMed ID: 15292713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study.
    Phuphanich S; Baker SD; Grossman SA; Carson KA; Gilbert MR; Fisher JD; Carducci MA
    Neuro Oncol; 2005 Apr; 7(2):177-82. PubMed ID: 15831235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.